Factors affecting willingness to provide buprenorphine treatment.

Journal of Substance Abuse Treatment
Julie NetherlandBHIVES Collaborative

Abstract

Buprenorphine is an effective long-term opioid agonist treatment. As the only pharmacological treatment for opioid dependence readily available in office-based settings, buprenorphine may facilitate a historic shift in addiction treatment from treatment facilities to general medical practices. Although many patients have benefited from the availability of buprenorphine in the United States, almost half of current prescribers are addiction specialists suggesting that buprenorphine treatment has not yet fully penetrated general practice settings. We examined factors affecting willingness to offer buprenorphine treatment among physicians with different levels of prescribing experience. Based on their prescribing practices, physicians were classified as experienced, novice, or as a nonprescriber and asked to assess the extent to which a list of factors impacted their prescription of buprenorphine. Several factors affected willingness to prescribe buprenorphine for all physicians: staff training; access to counseling and alternate treatment; visit time; buprenorphine availability; and pain medications concerns. Compared with other physicians, experienced prescribers were less concerned about induction logistics and access to expert ...Continue Reading

References

Jan 1, 1991·Journal of Substance Abuse Treatment·D M Novick, H Joseph
Sep 10, 1994·BMJ : British Medical Journal·P WilsonG E Ralston
Oct 1, 1996·The American Journal of Medicine·P G O'Connor, J H Samet
May 16, 1998·American Journal of Public Health·H M RhoadesJ Grabowski
Mar 14, 2000·JAMA : the Journal of the American Medical Association·M Weinrich, M Stuart
Jul 6, 2000·Annals of Internal Medicine·P G O'Connor, D A Fiellin
May 10, 2001·JAMA : the Journal of the American Medical Association·C LaineB J Turner
May 16, 2001·Archives of General Psychiatry·Y I HserM D Anglin
Aug 2, 2001·The American Journal of Psychiatry·D A FiellinT R Kosten
Jun 6, 2002·Journal of General Internal Medicine·Joseph O MerrillKatharine A Bradley
Oct 16, 2002·Annals of Internal Medicine·David A Fiellin, Patrick G O'Connor
Aug 26, 2003·British Journal of Nursing : BJN·June Rogers
Jun 19, 2004·The American Journal on Addictions·Joyce C WestDarrel A Regier
Sep 29, 2004·Journal of Substance Abuse Treatment·David A FiellinThomas R Kosten
Aug 2, 2005·Pharmacology & Therapeutics·Andrew J Saxon, Dennis McCarty
Aug 19, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lynn E Sullivan, David A Fiellin
Feb 24, 2006·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·William C Becker, David A Fiellin
May 24, 2006·Journal of Substance Abuse Treatment·Hannah K KnudsenPaul M Roman
Dec 1, 2006·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Lynn E SullivanDavid A Fiellin
Sep 1, 2002·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·David A FiellinPatrick G O'Connor

❮ Previous
Next ❯

Citations

Mar 16, 2011·Archives of Internal Medicine·Daniel P AlfordJeffrey H Samet
Dec 18, 2008·Journal of General Internal Medicine·Joshua D LeeMarc N Gourevitch
Dec 18, 2008·Journal of General Internal Medicine·Declan T BarryDavid A Fiellin
Jul 21, 2011·Current Psychiatry Reports·Elizabeth M OlivaAlex H S Harris
Jul 13, 2013·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Hillary V KuninsChinazo O Cunningham
Oct 29, 2013·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Sharon J ParishJulia H Arnsten
Mar 2, 2011·Journal of Addiction Medicine·Hannah K KnudsenPaul M Roman
Nov 10, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Bruce R Schackman
Mar 10, 2015·Journal of the American Pharmacists Association : JAPhA·Bethany A DiPaula, Elizabeth Menachery
Jan 4, 2013·American Journal of Preventive Medicine·E Jennifer Edelman, David A Fiellin
Dec 25, 2012·The American Journal of Medicine·David A FiellinRichard S Schottenfeld
Aug 9, 2011·Journal of Substance Abuse Treatment·Traci R RieckmannAmanda J Abraham
Aug 5, 2010·Journal of Substance Abuse Treatment·Susan D WhitleyChinazo O Cunningham
Jul 6, 2010·Journal of Substance Abuse Treatment·Cynthia L ArfkenCharles Roberts Schuster
Aug 11, 2015·Addictive Behaviors·Stacey C SigmonRobert P Schwartz
Aug 16, 2011·The American Journal on Addictions·Erik W GundersonHerbert D Kleber
Jan 4, 2012·The American Journal on Addictions·Joseph TkaczCharles Ruetsch
Apr 27, 2013·The American Journal on Addictions·Amy YangChris-Ellyn Johanson
Mar 4, 2014·International Journal of Nursing Practice·Andrew CashinThomas Buckley
Nov 15, 2015·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Aaron D FoxChinazo O Cunningham
May 6, 2015·Preventive Medicine·Stacey C Sigmon
Jun 13, 2015·American Journal of Public Health·Christopher M JonesElinore McCance-Katz
Apr 7, 2015·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Carrie M FarmerBradley D Stein
Oct 10, 2014·Journal of Addictive Diseases·Michael A CucciareChristine Timko
Nov 30, 2016·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Sara L DoorleyChinazo O Cunningham
Mar 16, 2017·Journal of Psychoactive Drugs·Hannah K Knudsen, Jamie L Studts
Apr 6, 2017·Journal of Addiction Medicine·John R Brooklyn, Stacey C Sigmon
Aug 3, 2018·The Journal of Behavioral Health Services & Research·Hannah K Knudsen, Jamie L Studts
Feb 5, 2019·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Julia M ShiKathleen M Carroll
Jul 20, 2011·Journal of Addiction Medicine·Joann AlbrightCharles Ruetsch
Mar 23, 2019·The American Journal on Addictions·Sukhpreet KlairePouya Azar
Mar 8, 2018·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Lello TesemaDanny McCormick
Nov 26, 2019·Annals of Internal Medicine·Melissa B WeimerDavid A Fiellin
Dec 21, 2019·Addiction Science & Clinical Practice·Jarratt D PytellRyan Graddy
Jan 8, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Amanda J AbrahamPeter D Friedmann
Aug 10, 2016·Journal of Addiction Medicine·Declan T BarryBrent A Moore
Feb 26, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Linda WeissRuth Finkelstein
Mar 1, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·James E EganUNKNOWN BHIVES Collaborative

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.